Benoquin Cream
₹ 305.00 – ₹ 2,745.00
Product Description
TYPICAL USAGE
Topical application to treat uneven appearance of the skin due to loss of skin colour (vitiligo).
SIDE EFFECTS
Nausea, stomach upset, skin rash, acute toxicity.
DRUG INTERACTION
Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use.Keep a list of all your medications with you, and share the list with your doctor and pharmacist.
MECHANISM OF ACTION
Monobenzone is used to treat the uneven appearance of the skin due to a loss of skin color (vitiligo). It works by permanently removing color from normal skin located around skin with vitiligo. This will help to make the appearance of the skin more even.Do not use this drug to treat other skin discoloration problems (“”sun spots,”” “”age spots,”” freckles, skin discoloration caused by hormone medicine, perfumes, pregnancy, or skin trauma). Monobenzone is not a mild cosmetic bleach. Because it causes a permanent discoloration of the skin, it may not be the right treatment for these other skin conditions.
INTERACTIONS
IMPACT ON PREGNANCY
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
IMPACT DURING LACTATION
There is positive evidence of risk to a breastfed infant or to breastmilk production, but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant (e.g. if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
Additional Information
Quantity | 10Pack*20gm, 1Pack*20gm, 5Pack*20gm |
---|
Reviews
There are no reviews yet.